Mechanisms of resistance to anti-EGFR therapy in colorectal cancer. - Abstract - Europe PMC
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study - The Lancet Oncology
Epidermal growth factor receptor (EGFR)-related signaling pathway in... | Download Scientific Diagram
Hexameric procyanidins inhibit colorectal cancer cell growth through both redox and non-redox regulation of the epidermal growth factor signaling pathway - ScienceDirect
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives - Annals of Oncology
Colorectal adenocarcinoma‐derived EGFR mutants are oncogenic and sensitive to EGFR‐targeted monoclonal antibodies, cetuximab and panitumumab - Kim - 2020 - International Journal of Cancer - Wiley Online Library
Y‑box‑binding protein 1 inhibits apoptosis and upregulates EGFR in colon cancer
Toward an individualizing therapy for colorectal cancer: the example of the anti-EGFR monoclonal antibodies | Personalized Medicine
APMG Colon Molecular Pathways
Feedback activation of EGFR/wild-type RAS signaling axis limits KRASG12D inhibitor efficacy in KRASG12D-mutated colorectal cancer | Oncogene
Clinical management of metastatic colorectal cancer in the era of precision medicine - Ciardiello - 2022 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Biomarkers in colorectal cancer: Current clinical utility and future perspectives
Cancers | Free Full-Text | Immune Resistance and EGFR Antagonists in Colorectal Cancer
New combination therapy offers bowel cancer patients extra treatment option
The Role of the Epidermal Growth Factor Receptor in the Mechanism and Treatment of Colorectal Cancer - Nirit Yarom - Discovery Medicine
Biomarkers in Targeted Therapy for Colorectal Cancer
Biomarqueurs des cancers colorectaux utiles en pratique clinique – FMC-HGE
Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic
Different EGFR signalling pathways induced by the interaction between... | Download Scientific Diagram
EGFR signaling in colorectal cancer: a clinical perspective | GICTT
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
![PDF] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2e5f89dec8a25afc1d61dc3d7197afa33839845d/3-Figure2-1.png "PDF] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer | Semantic Scholar")
PDF] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer | Semantic Scholar
Precision medicine for metastatic colorectal cancer in clinical practice - Julian E. Riedesser, Matthias P. Ebert, Johannes Betge, 2022
